Go Pro
→ Buffett's Final Warning: 'The Dollar Is Going to Hell' (From Decentralized Masters) (Ad)tc pixel Free RDY Stock Alerts

Dr. Reddy's Laboratories (RDY) News Today

Dr. Reddy's Laboratories logo
$11.70 -0.19 (-1.56%)
As of 11:12 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Dr. Reddy's Laboratories Latest News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
September 8 at 5:42 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3358218/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-dr-reddy-s-laboratories-limited-rdy.html
Nykredit A S Takes $2 Million Position in Dr. Reddy's Laboratories Ltd $RDY
September 8 at 4:07 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nykredit-a-s-takes-2-million-position-in-dr-reddys-laboratories-ltd-rdy-2026-09-08/
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
September 3, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-dr-reddys-laboratories-limited---rdy-302868540.html
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
September 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354704/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-dr-reddy-s-laboratories-limited-rdy.html
Dr. Reddy's Laboratories (NYSE:RDY) Upgraded to Hold at Wall Street Zen
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-dr-reddys-laboratories-nyse-rdy-upgraded-to-hold-at-wall-street-zen-2026-08-29/
Dr. Reddy's Laboratories Ltd $RDY Shares Sold by Bank of America Corp DE
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dr-reddys-laboratories-ltd-rdy-shares-sold-by-bank-of-america-corp-de-2026-08-28/
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
August 27, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-dr-reddys-laboratories-limited---rdy-302862236.html
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
August 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/25/3350986/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-dr-reddy-s-laboratories-limited-rdy.html
Securities Fraud Investigation Into Dr. Reddy's Laboratories (RDY) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
August 19, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/08/19/10432956.htm
Securities Fraud Investigation Into Dr. Reddy's Laboratories (RDY) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
August 19, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260819170238/en/securities-fraud-investigation-into-dr.-reddy%e2%80%99s-laboratories-rdy-announced-%e2%80%93-shareholders-who-lost-money-urged-to-contact-the-law-offices-of-frank-r.-cruz/
RDY SHAREHOLDER ALERT: Dr. Reddy's Laboratories Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
August 13, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260813865879/en/rdy-shareholder-alert-dr.-reddy%e2%80%99s-laboratories-investors-encouraged-to-contact-kirby-mcinerney-llp-about-potential-securities-laws-violations/
Dr. Reddy's Laboratories Ltd. Sponsored ADR
August 12, 2026  |  cnn.comhttps://www.cnn.com/markets/stocks/RDY
Zacks Research Issues Optimistic Forecast for RDY Earnings
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/zacks-research-issues-optimistic-forecast-for-rdy-earnings-2026-08-12/
Zacks Research Issues Pessimistic Outlook for RDY Earnings
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/zacks-research-issues-pessimistic-outlook-for-rdy-earnings-2026-08-11/
Dr. Reddy's Laboratories Launches Sugammadex Injection Single-Dose Vials in US
August 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/dr-reddy-apos-laboratories-launches-092633479.html
DR. REDDY'S LABORATORIES INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3339873/937/en/dr-reddy-s-laboratories-investor-alert-kirby-mcinerney-llp-announces-investigation-into-potential-securities-fraud.html
Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of ...
August 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/dr-reddy-announces-first-market-053900460.html
Dr. Reddy's Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States
August 4, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260729613216/en/Dr.-Reddy%E2%80%99s-Announces-the-First-to-Market-Launch-of-Sugammadex-Injection-200-mg2-mL-100-mgmL-and-500-mg5-mL-100-mgmL-Single-Dose-Vials-a-Generic-Equivalent-of-Bridion%C2%AE-in-the-United-States/
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
July 31, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/dr-reddys-laboratories-rdy-securities-investigation-notice---levi--korsinsky-302839636.html
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Dr. Reddy's Laboratories (RDY)
July 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/29/3335383/3080/en/levi-korsinsky-notifies-investors-of-pending-investigation-into-securities-claims-involving-dr-reddy-s-laboratories-rdy.html
Dr Reddys Laboratories Ltd (RDY)
July 28, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/insider-trading/company/dr+reddys+laboratories+ltd/1135951/news/
Dr Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call Highlights: Navigating Challenges and ...
July 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/dr-reddys-laboratories-ltd-rdy-010134110.html
RDY Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Dr. Reddy's Laboratories (RDY)
July 28, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260728610600/en/rdy-investor-alert-levi-korsinsky-notifies-investors-of-investigation-into-dr.-reddy%e2%80%99s-laboratories-rdy/
Dr. Reddy's Laboratories Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Dr. Reddy's Laboratories (RDY)
July 24, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/dr-reddys-laboratories-investigation-notice-levi--korsinsky-notifies-investors-of-pending-investigation-into-dr-reddys-laboratories-rdy-302834386.html
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
July 23, 2026  |  cnbc.comhttps://www.cnbc.com/2026/07/24/us-to-see-higher-generic-drug-prices-on-tariffs-indian-pharma-ceo.html
Why Dr. Reddy's sank: Profit plunge, semaglutide setback and Trump's tariff threat
July 22, 2026  |  msn.comhttps://www.msn.com/en-us/money/news/why-dr-reddys-sank-profit-plunge-semaglutide-setback-and-trumps-tariff-threat/ar-AA28tpzu
Dr. Reddy's Laboratories Limited (RDY) Q1 2027 Earnings Call Transcript
July 22, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4924282-dr-reddys-laboratories-limited-rdy-q1-2027-earnings-call-transcript
Dr. Reddy's falls after Q1 results amid Trump’s tariff threat
July 22, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4616630-dr-reddys-down-q1-results-amid-tariff-threat
Indian drugmaker Dr Reddy's posts quarterly profit slump
July 22, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/indian-drugmaker-dr-reddys-posts-quarterly-profit-slump-2026-07-22/
Dr. Reddy's Q1 earnings preview
July 21, 2026  |  msn.comhttps://www.msn.com/en-us/health/medical/dr-reddys-q1-earnings-preview/ar-AA28ofbN
Dr. Reddy's Laboratories (RDY) Projected to Release Quarterly Earnings on Wednesday
July 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/dr-reddys-laboratories-rdy-projected-to-release-quarterly-earnings-on-wednesday-2026-07-15/
Dr. Reddy's Laboratories Limited (RDY) Discusses Manufacturing Issue and Process Review for Semaglutide Transcript
July 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4921184-dr-reddys-laboratories-limited-rdy-discusses-manufacturing-issue-and-process-review-for
Dr. Reddy's falls as quality issue delays supplies of Ozempic generic
July 9, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4612628-dr-reddys-delays-supplies-ozempic-generic
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice
July 9, 2026  |  reuters.comhttps://www.reuters.com/legal/litigation/indias-torrent-pharma-recalls-select-semaglutide-pens-after-dr-reddys-notice-2026-07-09/
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
June 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/dr-reddy-laboratories-limited-announces-151000314.html
Dr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-F
June 26, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260626184427/en/dr.-reddy%e2%80%99s-laboratories-limited-announces-filing-of-annual-report-on-form-20-f/
Dr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
June 13, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260613138727/en/dr.-reddy%e2%80%99s-announces-the-first-to-market-launch-of-bosutinib-tablets-400mg-a-generic-equivalent-of-bosulif%c2%ae-in-the-united-states/
NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY
May 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/nyse-content-update-dell-technologies-reports-88-revenue-increase-yoy-302785646.html
Dr. Reddy’s Launches First Generic Semaglutide Injection in Canada After Health Canada Nod
May 17, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/RDY/pressreleases/1978129/dr-reddys-launches-first-generic-semaglutide-injection-in-canada-after-health-canada-nod/
Dr. Reddy's launches generic semaglutide in Canada, expands GLP-1 push
May 16, 2026  |  msn.comhttps://www.msn.com/en-us/money/general/dr-reddy-s-launches-generic-semaglutide-in-canada-expands-glp-1-push/ar-AA23n6e6
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
May 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260515689507/en/dr.-reddys-laboratories-launches-its-generic-semaglutide-injection-in-canada/
Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2026 Earnings Call Transcript
May 13, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/dr-reddys-laboratories-limited-nyserdy-q4-2026-earnings-call-transcript-1761093/
Dr. Reddy's Laboratories Ltd (RDY) Releases Q4 2026 Earnings: Revenue and Profits Plunge, Margins Compressed
May 12, 2026  |  quiverquant.comQ
Dr. Reddy's Laboratories Limited (RDY) Q4 2026 Earnings Call Transcript
May 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4903152-dr-reddys-laboratories-limited-rdy-q4-2026-earnings-call-transcript
Indian drugmaker Dr Reddy's posts quarterly profit slump
May 12, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/indian-drugmaker-dr-reddys-posts-quarterly-profit-slump-2026-05-12/
Canada Approves Dr. Reddy's Generic Version of Novo Nordisk's Ozempic
April 29, 2026  |  wsj.comhttps://www.wsj.com/health/pharma/canada-approves-dr-reddys-generic-version-of-novo-nordisks-ozempic-3e75dc6e
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
April 29, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260429333344/en/dr.-reddys-laboratories-announces-health-canada-approval-for-generic-semaglutide-injection-in-canada/
Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's
March 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/zacks-industry-outlook-highlights-teva-085700135.html
Dr. Reddy’s biosimilar for Bristol’s Orencia undergoes FDA review
February 20, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4554764-dr-reddys-biosimilar-bristols-orencia-gets-fda-review
Dr. Reddy's Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
February 20, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260220372110/en/dr.-reddy%e2%80%99s-announces-usfda-acceptance-to-review-its-biologics-license-application-bla-for-proposed-interchangeable-biosimilar-abatacept/

Dr. Reddy's Laboratories Media Mentions By Week

Dr. Reddy's Laboratories Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RDY
News Sentiment
▼
0.58

0.75
▲
Average
Healthcare
News Sentiment

Dr. Reddy's Laboratories News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RDY Articles
This Week
▼
3

2
▲
RDY Articles
Average Week

Dr. Reddy's Laboratories Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
1
Page Views
2,858
+31%
Get Dr. Reddy's Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Dr. Reddy's Laboratories dated 9/8/2026.
From Our Partners
Gold Explorer Sits Between Barrick’s Nevada Giants
Barrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldru...
Wall Street Logic | Sponsoredtc pixel
Shocking AI prediction from the “Billionaire Whisperer"
Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...
Chaikin Analytics | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Three under-the-radar companies are already building the infrastructure behind a 200 billion government-backed...
Eagle Publishing | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...
Decentralized Masters | Sponsoredtc pixel
The 2026 beginners Guide to Gold IRAs
Gold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...
Goldco Direct, LLC | Sponsoredtc pixel
American retirees will miss THIS. Big Banks just moved in.
Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...
Cedar Gold Group | Sponsoredtc pixel
Elon Musk’s Hushed FCC Filing. Sept 25th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...
Paradigm Press | Sponsoredtc pixel